Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012:2012:980250.
doi: 10.1155/2012/980250. Epub 2012 Mar 15.

scFv antibody: principles and clinical application

Zuhaida Asra Ahmad  1 , Swee Keong Yeap, Abdul Manaf Ali, Wan Yong Ho, Noorjahan Banu Mohamed Alitheen, Muhajir Hamid
Affiliations
Review

scFv antibody: principles and clinical application

Zuhaida Asra Ahmad et al. Clin Dev Immunol. 2012.

Abstract

To date, generation of single-chain fragment variable (scFv) has become an established technique used to produce a completely functional antigen-binding fragment in bacterial systems. The advances in antibody engineering have now facilitated a more efficient and generally applicable method to produce Fv fragments. Basically, scFv antibodies produced from phage display can be genetically fused to the marker proteins, such as fluorescent proteins or alkaline phosphatase. These bifunctional proteins having both antigen-binding capacity and marker activity can be obtained from transformed bacteria and used for one-step immunodetection of biological agents. Alternatively, antibody fragments could also be applied in the construction of immunotoxins, therapeutic gene delivery, and anticancer intrabodies for therapeutic purposes. This paper provides an overview of the current studies on the principle, generation, and application of scFv. The potential of scFv in breast cancer research is also discussed in this paper.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Antibody model showing subunit composition and domain distribution along the polypeptide chains. Single-chain fragment variable (scFv) antibody generated by recombinant antibody technology appears in the shaded area.
Figure 2
Figure 2
Structure of a filamentous phage displaying scFv fragments on its surface [14].
See this image and copyright information in PMC

References

    1. A. Janeway C, Travers P, Walport M, et al. Immunobiology. 5th edition. Garland Publishing; 2001.
    1. Rogozin IB, Solovyov VV, Kolchanov NA. Somatic hypermutagenesis in immunoglobulin genes. I. Correlation between somatic mutations and repeats. Somatic mutation properties and clonal selection. Biochimica et Biophysica Acta. 1991;1089(2):175–182. - PubMed
    1. Dimitrov DS, Marks JD. Therapeutic antibodies: current state and future trends—is a paradigm change coming soon? Methods in Molecular Biology. 2009;525:1–27. - PMC - PubMed
    1. Boss MA, Kenten JH, Wood CR, Emtage JS. Assembly of functional antibodies from immunoglobulin heavy and light chains synthesised in Escherichia coli . Nucleic Acids Research. 1984;12(9):3791–3806. - PMC - PubMed
    1. Kontermann RE, Müller R. Intracellular and cell surface displayed single-chain diabodies. Journal of Immunological Methods. 1999;226(1-2):179–188. - PubMed

MeSH terms